Related Experiment Video
Updated: Jun 25, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Left ventricular hypertrophy and geometry in hypertensive patients with chronic kidney disease
Emilio Nardi1, Alessandro Palermo, Giuseppe Mulè
1Dipartimento di Medicina Interna, Cattedra di Medicina Interna and Hypertension Excellence Centre of the European Society of Hypertension, Università degli Studi di Palermo, Palermo, Italy. emilionardi@virgilio.it
Insights
Left ventricular hypertrophy (LVH) is common in chronic kidney disease (CKD) patients, often inappropriate and linked to worsening renal function. This study compared LVH in hypertensive patients with CKD versus those with normal kidney function.
Area of Science:
- Cardiology
- Nephrology
- Clinical Hypertension
Background:
- Hypertension is a major risk factor for cardiovascular complications.
- Chronic kidney disease (CKD) is associated with increased cardiovascular morbidity and mortality.
- Left ventricular hypertrophy (LVH) is a common cardiac adaptation in hypertensive patients.
Purpose of the Study:
- To determine the prevalence of LVH and left ventricular geometry in hypertensive patients with stages 2-5 CKD.
- To compare LVH and geometry between hypertensive patients with CKD and those with normal renal function.
Main Methods:
- Echocardiographic examination was performed on 293 hypertensive patients with CKD (stage 2-5) and 289 hypertensive patients with normal renal function.
- Exclusion criteria included stage 1 CKD, dialysis, and pre-existing cardiovascular diseases.
Main Results:
- LVH prevalence was significantly higher in CKD patients (47.1%) compared to controls (31.14%).
- CKD patients showed increased left ventricular diameters, thicknesses, and mass, particularly in advanced stages.
- Inappropriate left ventricular mass was more prevalent in CKD patients (52.6%) vs. controls (30.5%).
- Renal function independently associated with left ventricular mass; diastolic function was impaired in CKD patients.
Conclusions:
- LVH is highly prevalent in hypertensive patients with CKD.
- LVH in CKD patients is often inappropriate, with increased wall thickness and diameter.
- Worsening renal function correlates with increased left ventricular mass and impaired diastolic function.
Objective:
To evaluate the prevalence of left ventricular hypertrophy (LVH) and left ventricular geometry in a group of 293 hypertensive patients with stage 2-5 chronic kidney disease (CKD), compared with 289 essential hypertensive patients with normal renal function.
Methods:
All patients underwent echocardiographic examination. Patients on stage 1 CKD, dialysis treatment, or with cardiovascular diseases were excluded.
Results:
LVH was observed in 47.1% of patients with CKD and in 31.14% of essential hypertensive patients (P < 0.0001). We found increasingly higher left ventricular diameters, thicknesses, and mass from stage 2 to 5 CKD. Distribution of concentric and eccentric LVH was not different between the two groups. However, after introducing mixed hypertrophy, the difference between the two groups group was disclosed (P = 0.027). The prevalence of inappropriate left ventricular mass was 52.6% in patients with CKD vs. 30.5% in essential hypertensive patients (P < 0.0001). Multiple regression analysis confirmed that the association between renal function and left ventricular mass (beta -0.287; P < 0.0001) was independent by potential confounders. From stage 4 to 5, the significant increase of left ventricular mass was due to growth in posterior wall thickness rather than end-diastolic diameter. Diastolic function was significantly worse in patients with CKD, especially in more advanced stages.
Conclusion:
Our study confirms that LVH is highly prevalent in patients with CKD; in this population, LVH is often inappropriate and characterized by the simultaneous increase of wall thicknesses and diameters.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Regurgitation I: Introduction
Pathophysiology of Heart Failure
Chronic Kidney Disease IV: Nursing Management
Heart Failure Drugs: Diuretics
